Several Cord Blood (CB) Bank studies suggested that ethnicity impaired CB unit (CBU) qualification. The Bone Marrow Donors Worldwide registries present an over-representation of unrelated donors (UD) from Northwestern European descent. This raises the question of equality of access to hematopoietic stem cells transplant, especially in the Mediterranean zone, which has taken in many waves of immigration. The aim of our study is to address whether, in the Marseille CB Bank, CBU qualification rate is impaired by geographic origin. The study compared biological characteristics of 106 CBU disqualified for total nucleated cell (TNC) count (dCBU) and 136 qualified CBU in relation to registry enrichment and haplotype origin. A high proportion (480%) of both dCBU and CBU had at least one non-European haplotype and enrich CB and UD registries to a higher extent than those with two European haplotypes (P o 0.001). No difference was observed between TNC count and volume according to geographic origin. Our study shows that diverse Mediterranean origins do not have an impact on the CBU qualification rate. Partnership with Mediterranean birth clinics with highly trained staff is a reasonable option to increase the HLA diversity of CB Bank inventories and to improve the representation of minorities.
INTRODUCTION
Hematopoietic stem cells are commonly used to restore the hematopoietic system after high-dose chemotherapy. The choice of the hematopoietic stem cell source depends mainly on HLA compatibility, total nucleated cell counts (TNCCs) of the Cord Blood Unit (CBU) available and the experience of the graft center.
1,2 Advantages of CBU recruitment compared with peripheral blood and BM are immediate availability, improved access to transplant, especially for ethnic minorities 3, 4 and their biological properties detailed in a graft context in many reviews. 2, 5 The main drawbacks of CBU are their low TNC and progenitor content. In France, qualification criteria are established by the Réseau Français du Sang Placentaire. The volume of the UCB has to be 470 mL and the TNCC 4140 × 10 7 . Many studies have shown that volume and TNC and progenitor counts are correlated. [6] [7] [8] [9] [10] Besides CBU cell content, a central issue of CB banking raised by many authors is HLA diversity. Indeed, the Bone Marrow Donors Worldwide collaboration of registries presents a lack of genetic diversity with an over-representation of donors from Northwestern European descent. 4, 6, 7, [10] [11] [12] [13] [14] Thus, patients with non-European ancestry have lower odds of obtaining a graft with high HLA compatibility and/or high TNCC. [13] [14] [15] [16] These studies highlight the importance of developing CB banking in partnership with birth clinics that care for pregnant women originating from populations that are underrepresented in existing CBBs and registries.
A potential drawback of this strategy is that ethnicity may affect the proportion of collected CBU with high cell numbers. 4, 10, 11, 15, [17] [18] [19] According to some studies, CBU from Caucasian donors display significantly higher volumes, and TNCC, CD34+ cell or CFU-GM counts. 4, 6, 7, 10, 11, 17 This queries the existence of a difference in CBU volume and TNCC according to donor geographical origin in other regions than North America. The Mediterranean zone was originally populated by specific Paleolithic, Neolithic and Iron migration routes. 20 Moreover, several waves of immigration throughout history, drained by the urban area of Marseille, have considerably enriched the genetic background of its population. In 2011, Marseille had 67 936 foreigners and 62 016 naturalized French citizens out of 850 636 inhabitants. Foreigners (49.2%) were from Maghreb (Morocco, Algeria and Tunisia), 18.9% were from the rest of Africa, 7.5% were from Spain, Italy or Portugal and 6.9% were from other countries of the European Union. 21 This census does not encompass foreigners' birth rates or their descents.
A previous study showed that 60% of 328 banked CBU collected by the Marseille Cord Blood Bank in a Marseille maternity ward had at least one haplotype denoting a non-European origin, of which 92 and 59% enriched the Cord Blood (CB) and Unrelated Donors (UD) registries, respectively. 22 However, one could argue that the highest genetic diversity would be found among disqualified CB; such a hypothesis would annul the benefit of recruitment among a genetically diverse population. The aim of our study is to address whether, in a Birth Clinic in the Mediterranean zone, geographic origin and registry enrichment affected the proportion of CBU that met qualification criteria and their biological characteristics.
MATERIALS AND METHODS

CBUs collected in Marseille and UDs from the RFGM in Southeastern France
The study was performed between May 2012 and August 2013 at the Hôpital de la Conception Birth Clinic (part of the Assistance Publique des Hôpitaux de Marseille, AP-HM, the University Hospital in Marseille). Hundred and six disqualified CBU (dCBU) were analyzed and compared with qualified CBU collected during the same period and by the same staff. dCBU were disqualified for TNCC count ( o140 × 10 7 ), their volume was over 70 mL. The number of qualified CBU included (136) was calculated based on the disqualification rate for each month. Réseau Français du Sang Placentaire qualification criteria were a minimal volume of 70 mL and a TNCC 4140 × 10 7 . Blood samples from the mother were also collected, as per standard operating procedures. A total of 2691 unrelated donors (UDs) from the same geographical area already analyzed by Magalon et al. 22 were also included.
HLA typing
Semiallelic HLA-A, HLA-B and allelic HLA-DRB1 genotyping was performed by molecular techniques for dCBUs and CBUs using a sequence-specific oligonucleotide technique for loci A and B (Labtype SSO kit, One Lambda, Inc., Canoga Park, CA, USA) and a sequence-specific priming technique for locus DRB1 (Olerup SSP, Olerup, Stockholm, Sweden). Semiallelic HLA-A and HLA-B genotyping for maternal samples was performed using the sequence-specific oligonucleotide technique.
Identification of putative HLA haplotypes associated with dCBU and CBUs collected in Marseille and broad determination of the geographic origin of parents Because of French legal restrictions, no self-reported ethnicity could be collected from the women; therefore, haplotype geographic origin was used in this study. The analytical methodology to identify putative HLA haplotypes described by Magalon et al. 22 was used. Briefly, putative dCBU and CBU haplotypes were deduced by confronting their full HLA type and the mother's partial HLA type with data available and published by Maiers and colleagues in 2007. Searching the database for putative haplotypes associated with the dCBU or CBU HLA-A, HLA-B and HLA-DRB1 types allowed us to speculate about the geographic origin of both parents, using the known frequency of their distribution across populations with different ethnic backgrounds. Consequently, several groups of dCBU and CBU were made up for further analyses: groups in which both parents probably had the same geographical origin (European, Afro-American, Hispanic and Asian) and a group in which both parents probably had different geographical origins ('different' geographic origin). In the remaining cases, at least one of the two haplotypes was not retrieved from the Maiers National Marrow Donor Program ('Undetermined' geographic origin of haplotype).
Assessment of the potential and actual enrichment of registries by the dCBU and CBU
The potential and actual enrichment of international UD and CB registries by the dCBU and CBU was assessed using the Bone Marrow Donor Worldwide database 05/2014 and simulating a search for a potential recipient. A dCBU or a CBU was considered to enrich the registry with a nonreferenced phenotype when no 6/6 matched CB or UD was identified in the respective registries, considering generic resolution for HLA-A, HLA-B and allelic resolution for HLA-DRB1. When the HLA type of a Marseille dCBU or CBU was already present, the number of 6/6 compatible CBUs already registered was determined.
Quality criteria assessment
Qualification standards were compared between dCBU and CBU according to registry enrichment or haplotype origin.
The volumes of collected CBU (over 70 mL) were recorded upon arrival at the cell-processing laboratory, after transportation from one site to the other. TNCs were counted in CBU samples before processing and freezing using a hematology analyzer (ABX Micros 60, ABX-Horiba, Montpellier, France). CD34+ cell counting was performed after miniaturization processing by flow cytometry (Cytomics FC500, Beckman Coulter, Fullerton, CA, USA) using a standardized Flow Count-based Stem-kit (Beckman Coulter) and automatic analysis software (StemCXP, Beckman Coulter).
Statistical analyses
Statistical analyses were performed using statistical software (SPSS 16.0, SPSS, Inc., Chicago, IL, USA). All statistical tests were two sided at the 5% level of significance. Phenotype frequencies were obtained for CBU and UD populations by dividing the number of subjects possessing the phenotype by the total number of subjects in the sample. Phenotype frequencies were compared using Yates' χ 2 -test. Volume, TNC and CD34+ cell count means were compared between dCBU and CBU that did or did not enrich CB or UD registries. We also compared these criteria for dCBU or CBU obtained when parents had two haplotypes of European geographic origin versus dCBU or CBU hypothetically obtained with parents who had at least one haplotype not identified as being European. Means were compared using a Kruskal-Wallis test. Finally, different groups of equal distribution were made up to assess whether frequencies of dCBU and CBU enriching registries or not were different, based on the TNC count before freezing and processing ( 
RESULTS
The putative geographic origin of the parents of infants, from whom dCBU and CBU were obtained, was deduced from HLA Abbreviations: CB = cord blood; CBU = CB unit; dCBU = disqualified CBU; UD = unrelated donor. N stands for number and F for frequency (%).
Ethnicity and CBU qualification in Marseille CBB C Bordoni et al typing of infants and mothers, providing parental haplotypes that were compared with Maiers et al database. Haplotypes were classified as « 2 Europeans » or « at least 1 non-European » (Table 1 ). In this latter group, non-European haplotypes were further defined as Afro-American, Hispanic, Asian, Different or Undetermined. A similarly high proportion of dCBU and CBU had at least one non-European haplotype (83% and 84%, respectively). Importantly, both dCBU and CBU presented a high genetic Abbreviations: CB = cord blood; dCBU = disqualified CB unit; TNC = total nucleated cell; UD = unrelated donor. N stands for number, F for frequency (%). Abbreviations: CB = cord blood; CBU = CB unit; dCBU = disqualified CBU; TNC = total nucleated cell; UD = unrelated donor. N stands for number, F for frequency (%).
diversity, as respectively, 71% and 75% had two haplotypes of different origins among European, Afro-American, Hispanic, Asian, Different or Undetermined groups. dCBU and CBU enriched the CB and UD registries in the same proportions (respectively, 70% vs 62% and 26% vs 24%). dCBU and CBU with at least one non-European haplotype enriched the UD and CB registries more significantly than dCBU and CBU with two European haplotypes (Po 0.001 respectively; for details see Table 1 ). Thus, the genetic diversity among dCBU, that is their registry enrichment potential, is similar to that of CBU.
With regard to haplotype-related geographic origin, no statistically significant difference was observed between TNC counts and volumes of all CBU (qualified and disqualified) with at least one non-European haplotype and those with two European haplotypes (Figures 1a and b) .
Considering the 106 dCBU, no statistical difference was observed between dCBU with at least one non-European haplotype and those with two European haplotypes in relation to volume (83.4 mL vs 90.2 mL), TNC count (104.4 × 10 7 vs 105.2 × 10 7 ) and TNC count distribution (Table 2) . Accordingly, no statistical difference was observed between CB registry enrichment and CB biological characteristics, that is, volume (88 mL vs 90 mL), TNCC (104.8 × 10 7 vs 104.8 × 10 7 ) and distribution (Table 2 ). Quartile distribution was homogeneous according to geographic origin and CB registry enrichment, a slight predominance effect for the third quartile (105-124 × 10 7 ), of no statistical significance, was observed for dCBU displaying no enrichment.
Taking the 136 qualified CBUs collected during the same period, mean TNCC was 198 × 10 7 and mean volume was 118 mL. No difference was observed in the TNCC and volume distribution between CBU with at least one non-European haplotype and those with two European haplotypes. Quartile distribution was homogeneous according to geographic origin and CB registry enrichment (Table 3) .
DISCUSSION
We show in this study that in the local context of Marseille, no difference was found between dCBU and CBU in terms of haplotype geographic origin and CB and UD registries enrichment. We confirm that the qualified CBU collected in the CBB of Marseille present high genetic diversity enriching the registries. 22 The potential and actual CB and UD registries enrichment that we observed among the dCBU and CBU bearing at least one nonEuropean haplotype are in accordance with the findings of Gragert et al. 13 These authors described that populations with a same origin as minorities living in Marseille, such as Middle Eastern or North African and African, have, respectively, 46% and 18% chance of finding a 8/8 HLA match adult donor and 6-18 and 1-5% chance (depending on patient's age) of finding a 6/6 HLA match CBU. 13 Our data suggest that the proportion of banked CBU, that is, TNCC above 140 × 10 7 and volume above 70 mL, is not affected by haplotype geographic origin. This result contradicts most American studies (see for review, Akyurekli et al. 19 ). Two explanations can support these discrepancies; first, the specific genetic background of Marseille and more widely of the Mediterranean area and second, the UCB collection mode used at the Hôpital de la Conception Birth Clinic of Marseille, where the proportion of collected CBU that were ultimately validated ranges among the highest in France (35% during the study period).
Whereas minority populations enriched the registries in both Northern American and Mediterranean areas, their behavioral, clinical, obstetrical and biological characteristics might not be equivalent. Birth weight, 6,7,23 length 8 and gender 4, 10, 17, 24 have been correlated with CBU volume and TNCC; as well as different obstetric parameters, such as placenta weight, 17 time of cord clamping and time of UCB collection after birth. 17, 23, 25 A Canadian study showed that birth weights from different ethnic groups are significantly different, and encouraged modification of birth weight curves according to ethnicity; it is interesting to note that Middle Eastern and North African populations present the closest mean birth weight to European and Western populations. 26 Concerning the staff dedicated to the UCB collection, Askari et al. 17 suggested that qualification rates are improved if two people are in charge of the birth and UCB collection; furthermore, Wang et al. 25 suggested that the more professionals are trained and experienced, the fewer CBU are disqualified. Thus, appropriate training and experience for UCB collection, as given by the Joint Accreditation Committee of the ISCT and EBMT standards (FACT-NETCORD), improve CBU qualification rates. 27 The CBB of Marseille have paid particular attention to professional training for UCB collection and awareness of CBB missions; furthermore, a specific organization has been set up with a nurse dedicated to collecting the mothers' details, whatever their origin, to recruitment and to UCB collection. Although such human investment has a financial repercussion for the CBB, this specific training and organization has led to a strong commitment of the birth clinic staff concerning the CBB issue.
As a conclusion, although the small sample size of the comparator cohort, that is CBU and dCBU with two haplotypes from European origin, our results show that diverse Mediterranean origins do not have an impact on the CBU qualification rate and that there is no need for the Marseille CBB to design a specific biological qualification algorithm according to donor geographic origin.
In perspective, a study carried out on the release of stored CBU according to HLA haplotype and/or donor ethnicity could help to evaluate the financial balance of CBBs which defend a policy of greater genetic diversity.
